Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting ...

San Francisco-based Trace Neuroscience has launched with $101 million in series A funding to develop ALS therapies focused on ...

Her husband, Scott Sessa, said that her death, in a hospital, was caused by complications of amyotrophic lateral sclerosis ...

Among the various forms of MND, amyotrophic lateral sclerosis (ALS) is most prevalent in the UK, impacting around 5,000 ...

Amyotrophic lateral sclerosis (ALS) is the most common form of MND and there is currently no cure for the condition which ...

Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...

The FDA initially halted the trials on 16 October after a patient in the Phase II trial (NCT05519839) of the CIC vaccine ...

Friends and family gathered on Friday night to bid farewell to community leader and nature promoter Omar Gallardo with an ...

Amyotrophic lateral sclerosis (ALS) is the most common form of MND and there is currently no cure for the condition which ...

The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...